Skip to main content

New First-Line Standard of Care for Esophageal Cancer?

Pembrolizumab (Keytruda) is already approved for use in the treatment of esophageal cancer, but in the second-line setting.

https://www.medscape.com/viewarticle/937827

AUDIENCES

SUBJECTS

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino